Skip to content
Home/Companies/Healthcare/PHARMA SANTE DEVELOPPEMENT

PHARMA SANTE DEVELOPPEMENT

Healthcare·France·Exited 2024·Held 7yr
Entry
2017
Hold
7yr
Exit
2024

Who owns PHARMA SANTE DEVELOPPEMENT?

PHARMA SANTE DEVELOPPEMENT was owned by Societe Generale Capital Partenaires through SGCP Evergreen (balance sheet) (1991 vintage) from 2017 to 2024.

Hand-verified · updated 2026-08-12

Societe Generale Capital Partenaires
Investor
Societe Generale Capital Partenaires
SGCP Evergreen (balance sheet) · 1991 · Evergreen

Key facts

HQFrance
SectorHealthcare
StatusAcquired
Exit Type
–
Buyer
–
MOIC
–
Exit Year
2024

More from SGCP Evergreen (balance sheet)

Other portfolio companies in the same fund.

Air Support
Air Support
Active
Aerospace & DefenceFrance· 2026
Lagarde Meregnani
Lagarde Meregnani
Active
ConstructionFrance· 2026
MJ Valorisation
Active
IndustrialsFrance· 2026
ZODIAC MILPRO
Zodiac Milpro
Active
IndustrialsFrance· 2026
CEVA SANTE ANIMALE
Ceva Sante Animale
Active
PharmaFrance· 2025
DESLOG
Deslog
Active
LogisticsFrance· 2025

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Track Pharma Sante Developpement

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Pharma Sante Developpement.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue